OCT 03, 2018 7:30 AM PDT

Keynote Presentation: Measurements and Standards to Support Confidence in Genome Editing

Presented at: CRISPR 2018
Speaker
  • Leader, Genome Editing Program, National Institute of Standards and Technology (NIST)
    Biography
      Samantha leads NIST's Genome Editing Program including the NIST Genome Editing Consortium, which supports measurements, standards and assay qualification for confidence in genome editing applications with an emphasis on gene and cell therapy. She has 13 years of experience working on projects supporting better measurements and assays for early detection of cancer biomarkers in collaboration with the National Cancer Institute's Early Detection Research Network. Her research is focused on measurement assurance and technology development for genome editing, bioassay and biomarker validation, with applications in engineering biology, precision/regenerative medicine, and cancer biology.

      Samantha also represents the U.S. as a technical expert to the International Standards Organizations Technical Committee on Biotechnology (ISO TC 276). She is currently a U.S. liaison representing the interests and expertise of the U.S. on standards relating to nucleic acids measurements.

    Abstract

    The National Institute of Standards and Technology (NIST), is the measurement institute of the U.S., supplying unbiased expertise in measurements and standards to support growth in all sectors of economy and commerce including healthcare and the bio-economy.  Confidence and comparability of measurements are critical to underpinning any scientific effort including the genome editing field.  Through a newly launched NIST-led Genome Editing Consortium, NIST is working with experts in the genome editing field to identify and develop solutions for pre-competitive needs for establishing confidence in assessing the results of genome editing process.  Leading pre-competitive needs the consortium will address are: shared process control samples, reference data and standard data formats, minimum information norms, and standard terminology. This talk will give an introduction measurement assurance and overview of the newly launched NIST-led Genome Editing Consortium.

    Learning Objectives: 

    1. Gain a better understanding of how community norms and standards can help give confidence in data and accelerate the genome editing field 
    2. Gain knowledge of the NIST Genome Editing Consortium and the ongoing efforts to develop genome editing community standards and norms


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    NOV 10, 2020 7:00 AM PST
    C.E. CREDITS
    NOV 10, 2020 7:00 AM PST
    DATE: November 10, 2020 TIME: 7:00am PDT, 10:00am EDT Automation can provide tremendous benefits such as increased pipetting precision and accuracy, productivity, and throughput. Numerous wo...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    DEC 03, 2020 4:30 PM PST
    C.E. CREDITS
    DEC 03, 2020 4:30 PM PST
    This drug development program is designed to create a family of broad-spectrum, pan-coronaviral drugs that respectively inhibit multiple key enzymes required for viral replication. By target...
    OCT 03, 2018 7:30 AM PDT

    Keynote Presentation: Measurements and Standards to Support Confidence in Genome Editing

    Presented at: CRISPR 2018

    Specialty

    Dna Sequencing

    Bioinformatics

    Gene Expression

    Cell Culture

    Biomarkers

    Gene Sequencing

    Dna

    Clinical Diagnostics

    Biotechnology

    Animal Models

    Gene Therapy

    Next-Generation Sequencing

    Flow Cytometry

    Gene Editing

    Rare Diseases

    Geography

    Europe75%

    Asia25%

    Registration Source

    Website Visitors100%

    Job Title

    Student50%

    Medical Doctor/Specialist25%

    Medical Laboratory Technician25%

    Organization

    Government25%

    Manufacturer - Other25%

    Research Institute25%

    Academic Institution25%


    Show Resources
    Loading Comments...
    Show Resources
    Attendees
    • See more